Mupirocin-Resistant, Methicillin-Resistant Staphylococcus aureus Strains in Canadian Hospitals
- 1 November 2007
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (11) , 3880-3886
Abstract
Mupirocin resistance in Staphylococcus aureus is increasingly being reported in many parts of the world. This study describes the epidemiology and laboratory characterization of mupirocin-resistant methicillin-resistant S. aureus (MRSA) strains in Canadian hospitals. Broth microdilution susceptibility testing of 4,980 MRSA isolates obtained between 1995 and 2004 from 32 Canadian hospitals was done in accordance with CLSI guidelines. The clinical and epidemiologic characteristics of strains with high-level mupirocin resistance (HLMup r ) were compared with those of mupirocin-susceptible (Mup s ) strains. MRSA strains were characterized by pulsed-field gel electrophoresis (PFGE) and typing of the staphylococcal chromosomal cassette mec . PCR was done to detect the presence of the mupA gene. For strains with mupA , plasmid DNA was extracted and subjected to Southern blot hybridization. A total of 198 (4.0%) HLMup r MRSA isolates were identified. The proportion of MRSA strains with HLMup r increased from 1.6% in the first 5 years of surveillance (1995 to 1999) to 7.0% from 2000 to 2004 ( P < 0.001). Patients with HLMup r MRSA strains were more likely to have been aboriginal (odds ratio [OR], 3.7; 95% confidence interval [CI], 1.5 to 9.4; P = 0.006), to have had community-associated MRSA (OR, 2.2; 95% CI, 1.0 to 5.0; P = 0.05), and to have been colonized with MRSA (OR, 1.7; 95% CI, 1.0 to 3.0; P = 0.04). HLMup r MRSA strains were also more likely to be resistant to fusidic acid (21% versus 4% for mupirocin-susceptible strains; P < 0.001). All HLMup r MRSA strains had a plasmid-associated mupA gene, most often associated with a 9-kb HindIII fragment. PFGE typing and analysis of the plasmid profiles indicate that both plasmid transmission and the clonal spread of HLMup r MRSA have occurred in Canadian hospitals. These results indicate that the incidence of HLMup r is increasing among Canadian strains of MRSA and that HLMup r MRSA is recovered from patients with distinct clinical and epidemiologic characteristics compared to the characteristics of patents with Mup s MRSA strains.Keywords
This publication has 49 references indexed in Scilit:
- Comparative Genomics of Canadian Epidemic Lineages of Methicillin-Resistant Staphylococcus aureusJournal of Clinical Microbiology, 2007
- Genetic Basis of Resistance to Fusidic Acid in StaphylococciAntimicrobial Agents and Chemotherapy, 2007
- High Frequencies of Clindamycin and Tetracycline Resistance in Methicillin-Resistant Staphylococcus aureus Pulsed-Field Type USA300 Isolates Collected at a Boston Ambulatory Health CenterJournal of Clinical Microbiology, 2007
- Clonal Dissemination and mupA Gene Polymorphism of Mupirocin-Resistant Staphylococcus aureus Isolates from Long-Term-Care Facilities in South KoreaAntimicrobial Agents and Chemotherapy, 2006
- Phenotypic and Genotypic Mupirocin Resistance among Staphylococci Causing Prosthetic Joint InfectionJournal of Clinical Microbiology, 2005
- Community-associated Methicillin-resistantStaphylococcus aureus, CanadaEmerging Infectious Diseases, 2005
- Methicillin-ResistantStaphylococcus aureusDisease in Three CommunitiesNew England Journal of Medicine, 2005
- Isoleucyl-tRNA Synthetase Mutations in Staphylococcus aureus Clinical Isolates and In Vitro Selection of Low-Level Mupirocin-Resistant StrainsAntimicrobial Agents and Chemotherapy, 2003
- Mupirocin resistance in methicillin-resistant Staphylococcus aureus clinical isolates in a Spanish hospital. Co-application of multiplex PCR assay and conventional microbiology methodsDiagnostic Microbiology and Infectious Disease, 2002
- Use of the Polymerase Chain Reaction for Rapid Detection of High-Level Mupirocin Resistance in StaphylococciEuropean Journal of Clinical Microbiology & Infectious Diseases, 1999